Brief: Xintela Granted Preliminary Approval From European Patent Office

Xintela AB

23/06/2020 10:17

June 23 (Reuters) - Xintela AB  XINT.ST :
    * XINTELA GRANTED PRELIMINARY APPROVAL FROM THE EUROPEAN
PATENT
OFFICE FOR THE TREATMENT OF BRAIN TUMORS
    * PATENT, WHICH BROADENS AND EXTENDS XINTELA'S FUNDAMENTAL
PROTECTION IN THIS FIELD, WILL BE VALID UNTIL 2036.
    * EUROPEAN PATENT OFFICE (EPO) HAS ISSUED A PRELIMINARY
APPROVAL
("INTENTION TO GRANT") FOR COMPANY'S PATENT APPLICATION

Source text for Eikon:  ID:nBQN51vzGv 
Further company coverage:  XINT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))